Diagnostic Tools Market Report 2026

Diagnostic Tools Market Report 2026
Global Outlook – By Component (Software, Services), By Deployment Mode (On-Premises, Cloud), By Organization Size (Small And Medium Enterprises, Large Enterprises), By Industry Vertical (Banking, Financial Services And Insurance (BFSI), Information Technology And Telecommunications, Healthcare, Retail, Manufacturing, Government, Other Industry Verticals) – Market Size, Trends, Strategies, and Forecast to 2035
Diagnostic Tools Market Overview
• Diagnostic Tools market size has reached to $43.96 billion in 2025 • Expected to grow to $58.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.8% • Growth Driver: Rising Infectious Diseases Driving Growth In The Market Due To Increasing Demand For Rapid And Accurate Pathogen Detection • Market Trend: Regulatory Approvals And Digital Pathology Platforms Strengthen Diagnostic Tools In Clinical Settings • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Diagnostic Tools Market?
Diagnostic tools are devices, applications, or methods used to detect diseases, disorders, or irregularities in medical conditions. They gather and evaluate information to identify the underlying cause of a health issue. Diagnostic tools are primarily used to enable early detection, enhance diagnostic accuracy, minimize health risks, and assist healthcare professionals in making well-informed treatment decisions. The main components of diagnostic tools are software and services. Software refers to digital platforms and applications that assist in analyzing, interpreting, and managing diagnostic data. hese solutions are deployed through on-premises and cloud-based models and cater to organizations of different sizes, including small and medium enterprises (SMEs) and large enterprises. The various applications involved span multiple industry verticals such as banking, financial services and insurance (BFSI), information technology and telecommunications, healthcare, retail, manufacturing, government, and others.
What Is The Diagnostic Tools Market Size and Share 2026?
The diagnostic tools market size has grown strongly in recent years. It will grow from $43.96 billion in 2025 to $46.41 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising demand for early disease detection, growth in healthcare infrastructure, adoption of laboratory testing devices, increasing government healthcare initiatives.What Is The Diagnostic Tools Market Growth Forecast?
The diagnostic tools market size is expected to see strong growth in the next few years. It will grow to $58.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to growing telemedicine adoption, rising investment in ai-driven diagnostics, expansion of wearable health monitoring devices, increasing focus on personalized medicine, growth in preventive healthcare services. Major trends in the forecast period include increasing adoption of remote patient monitoring tools, rising demand for point-of-care diagnostic devices, growth in imaging and radiology evaluation services, expansion of laboratory testing and sample analysis solutions, integration of multi-parameter health screening systems.Global Diagnostic Tools Market Segmentation
1) By Component: Software, Services 2) By Deployment Mode: On-Premises, Cloud 3) By Organization Size: Small And Medium Enterprises, Large Enterprises 4) By Industry Vertical: Banking, Financial Services And Insurance (BFSI), Information Technology And Telecommunications, Healthcare, Retail, Manufacturing, Government, Other Industry Verticals Subsegments: 1) By Software: Process Modeling And Design Software, Process Automation Software, Process Analytics And Monitoring Software, Process Integration Software, Case Management Software 2) By Services: Consulting Services, Implementation Services, Training And Education Services, Managed And Support Services, Process Optimization ServicesWhat Is The Driver Of The Diagnostic Tools Market?
The increasing prevalence of infectious diseases is expected to propel the growth of the diagnostic tools market going forward. Infectious diseases refer to conditions caused by pathogens that can be transmitted from one person, animal, or environment to another. The increase in infectious diseases is driven by urbanization and population growth, which bring more people into close contact, creating ideal conditions for pathogens to spread rapidly. Diagnostic tools help in infectious diseases by detecting and identifying the causative pathogens quickly and accurately, enabling timely treatment and preventing further spread. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the increasing prevalence of infectious diseases is driving the growth of the diagnostic tools industry.Key Players In The Global Diagnostic Tools Market
Major companies operating in the diagnostic tools market are F Hoffmann La Roche AG, Hitachi Ltd, Abbott Laboratories, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips NV, Fujifilm Holdings Corporation, Danaher Corporation, GE HealthCare Technologies Inc, Becton Dickinson and Company, Konica Minolta Inc, Shenzhen Mindray Bio Medical Electronics Co Ltd, Illumina Inc, bioMerieux SA, Hologic Inc, Shimadzu Corporation, Bio Rad Laboratories Inc, DiaSorin SpA, Carestream Health Inc, and Sanrad Medical Systems Private Limited.Global Diagnostic Tools Market Trends and Insights
Major companies operating in the diagnostic tools market are focusing on developing innovative solutions such as digital pathology platforms to enable faster, more accurate disease detection and streamline clinical workflows. A digital pathology platform refers to a technology system that digitizes tissue samples and biopsy slides using high-resolution scanners, allowing pathologists to view, analyze, and share images on a computer or cloud-based platform, often enhanced with AI tools for faster and more accurate disease diagnosis. For instance, in June 2025, PathAI Inc., a US-based technology company, launched AISight Dx, a digital pathology image management system that received approval from the Food and Drug Administration (FDA), enabling primary diagnosis use in clinical settings. It streamlines anatomic pathology workflows through intelligent case management, high-performance whole slide image review, multi-slide navigation, annotation tools, and real-time collaboration features. The system integrates with scanners like Hamamatsu NanoZoomer and Leica Aperio, boosting efficiency and diagnostic consistency for labs and hospitals.What Are Latest Mergers And Acquisitions In The Diagnostic Tools Market?
In October 2025, ARCHIMED Diagnostics, a France-based healthcare-focused investment firm, completed the acquisition of ARK Diagnostics for an undisclosed amount. Through this acquisition, ARCHIMED aims to expand its footprint in the in-vitro diagnostics (IVD) market by strengthening ARK Diagnostics’ specialized assay offerings and enhancing its global distribution capabilities in therapeutic drug monitoring and clinical toxicology testing. ARK Diagnostics is a US-based company that manufactures diagnostic tools, specifically in vitro diagnostic assay kits used for clinical diagnostics.Regional Insights
North America was the largest region in the diagnostic tools market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Diagnostic Tools Market?
The diagnostic tools market consists of revenues earned by entities by providing services such as screening and preventive health assessments, disease monitoring and progression tracking, laboratory testing and sample analysis, and imaging and radiology evaluation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic tools market also includes sales of electroencephalogram (EEG) systems, spirometers, blood glucose monitoring devices, and hematology analyzers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Diagnostic Tools Market Report 2026?
The diagnostic tools market research report is one of a series of new reports from The Business Research Company that provides diagnostic tools market statistics, including diagnostic tools industry global market size, regional shares, competitors with a diagnostic tools market share, detailed diagnostic tools market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic tools industry. This diagnostic tools market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.Diagnostic Tools Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $46.41 billion |
| Revenue Forecast In 2035 | $58.21 billion |
| Growth Rate | CAGR of 5.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Component, Deployment Mode, Organization Size, Industry Vertical |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | F Hoffmann La Roche AG, Hitachi Ltd, Abbott Laboratories, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips NV, Fujifilm Holdings Corporation, Danaher Corporation, GE HealthCare Technologies Inc, Becton Dickinson and Company, Konica Minolta Inc, Shenzhen Mindray Bio Medical Electronics Co Ltd, Illumina Inc, bioMerieux SA, Hologic Inc, Shimadzu Corporation, Bio Rad Laboratories Inc, DiaSorin SpA, Carestream Health Inc, and Sanrad Medical Systems Private Limited. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Diagnostic Tools market was valued at $43.96 billion in 2025, increased to $46.41 billion in 2026, and is projected to reach $58.21 billion by 2030.
request a sample hereThe global Diagnostic Tools market is expected to grow at a CAGR of 5.8% from 2026 to 2035 to reach $58.21 billion by 2035.
request a sample hereSome Key Players in the Diagnostic Tools market Include, F Hoffmann La Roche AG, Hitachi Ltd, Abbott Laboratories, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips NV, Fujifilm Holdings Corporation, Danaher Corporation, GE HealthCare Technologies Inc, Becton Dickinson and Company, Konica Minolta Inc, Shenzhen Mindray Bio Medical Electronics Co Ltd, Illumina Inc, bioMerieux SA, Hologic Inc, Shimadzu Corporation, Bio Rad Laboratories Inc, DiaSorin SpA, Carestream Health Inc, and Sanrad Medical Systems Private Limited..
request a sample hereMajor trend in this market includes: Regulatory Approvals And Digital Pathology Platforms Strengthen Diagnostic Tools In Clinical Settings. For further insights on this market.
request a sample hereNorth America was the largest region in the diagnostic tools market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic tools market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here